The PCR genotyping-adjusted cure rates at day 63 after treatment initiation were 95.7 % ( 95 % confidence interval [ 95 % CI ] , 92.2 % -98.9 % ) for MAS3 , 100 % for DP4 , and 99.4 % ( 95 % CI , 98.1 % -100 % ) for DP3 .
